Editors:
- GIVES BACKGROUND INFORMATION ABOUT THE DISCOVERY OF COX-2 PROVIDES AN EXCELLENT OVERVIEW OF THE PHARMACOLOGY AND TOXICOLOGY OF COX-2 AGENTS PROVIDES INFORMATION ABOUT EFFECTS OF COX-2
- ON THE CARDIOVASCULAR SYSTEM, LUNGS, KIDNEY, ULCERS AND REPRODUCTION
- TARGETS MAJOR BIOLOGICAL SYSTEMS WHERE COX-2 INHIBITORS HAVE THE POTENTIAL TO BE DIFFERENT FROM NON-SELECTIVE INHIBITORS AND REVIEWS EVIDENCE FOR AND AGAINST THIS
- Includes supplementary material: sn.pub/extras
Part of the book series: Milestones in Drug Therapy (MDT)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (11 chapters)
-
Front Matter
-
Back Matter
About this book
Editors and Affiliations
-
Department of Pulmonary Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a. d. Riss, Germany
Michel Pairet
-
Department Drug Discovery Support, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a. d. Riss, Germany
Joanne Ryn
Bibliographic Information
Book Title: COX-2 Inhibitors
Editors: Michel Pairet, Joanne Ryn
Series Title: Milestones in Drug Therapy
DOI: https://doi.org/10.1007/978-3-0348-7879-1
Publisher: Birkhäuser Basel
-
eBook Packages: Springer Book Archive
Copyright Information: Springer Basel AG 2004
Hardcover ISBN: 978-3-7643-6901-9Published: 29 March 2004
Softcover ISBN: 978-3-0348-9607-8Published: 05 November 2012
eBook ISBN: 978-3-0348-7879-1Published: 06 December 2012
Series ISSN: 2296-6056
Series E-ISSN: 2296-6064
Edition Number: 1
Number of Pages: X, 250
Topics: Pharmacology/Toxicology, Cell Biology, Immunology, Molecular Medicine, Pain Medicine